KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Inventory (2016 - 2025)

Biogen has reported Change in Inventory over the past 17 years, most recently at $29.4 million for Q4 2025.

  • Quarterly results put Change in Inventory at $29.4 million for Q4 2025, down 55.72% from a year ago — trailing twelve months through Dec 2025 was $64.7 million (down 76.37% YoY), and the annual figure for FY2025 was $64.7 million, down 76.37%.
  • Change in Inventory for Q4 2025 was $29.4 million at Biogen, up from $7.4 million in the prior quarter.
  • Over the last five years, Change in Inventory for BIIB hit a ceiling of $142.6 million in Q1 2022 and a floor of -$62.0 million in Q1 2025.
  • Median Change in Inventory over the past 5 years was $85.6 million (2021), compared with a mean of $62.6 million.
  • Biggest five-year swings in Change in Inventory: soared 630.39% in 2023 and later plummeted 179.79% in 2025.
  • Biogen's Change in Inventory stood at $139.8 million in 2021, then plummeted by 112.95% to -$18.1 million in 2022, then soared by 630.39% to $96.0 million in 2023, then tumbled by 30.83% to $66.4 million in 2024, then tumbled by 55.72% to $29.4 million in 2025.
  • The last three reported values for Change in Inventory were $29.4 million (Q4 2025), $7.4 million (Q3 2025), and $89.9 million (Q2 2025) per Business Quant data.